Walleye Capital LLC Organon & Co. Put Options Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$18.65 - $23.03 $757,190 - $935,018	-40,600 Reduced 20.93%	153,400 $2.93 Million
Q2 2024 Aug 14, 2024	SELL	$17.45 - $21.96 $472,895 - $595,116	-27,100 Reduced 12.26%	194,000 $4.02 Million
Q1 2024 May 15, 2024	BUY	$13.78 - $18.8 $2.79 Million - $3.8 Million	202,200 Added 1069.84%	221,100 $4.16 Million
Q4 2023 Feb 14, 2024	BUY	$10.95 - $17.32 $88,695 - $140,292	8,100 Added 75.0%	18,900 $272,000
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $18,249 - $26,147	1,100 Added 11.34%	10,800 $187,000
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $44,321 - $56,649	2,300 Added 31.08%	9,700 $201,000
Q1 2023 May 15, 2023	BUY	$21.42 - $32.08 $32,130 - $48,120	1,500 Added 25.42%	7,400 $174,000
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $137,529 - $168,799	5,900 New	5,900 $164,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.